Matches in Wikidata for { <http://www.wikidata.org/entity/Q90466619> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q90466619 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90466619 description "scientific article published on 03 October 2019" @default.
- Q90466619 description "wetenschappelijk artikel" @default.
- Q90466619 description "наукова стаття, опублікована 3 жовтня 2019" @default.
- Q90466619 name "The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models" @default.
- Q90466619 name "The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models" @default.
- Q90466619 type Item @default.
- Q90466619 label "The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models" @default.
- Q90466619 label "The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models" @default.
- Q90466619 prefLabel "The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models" @default.
- Q90466619 prefLabel "The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models" @default.
- Q90466619 P1433 Q90466619-7A444E5F-7E24-4B94-B2B6-269A119EF85E @default.
- Q90466619 P1476 Q90466619-64E3EC54-3B31-443E-8A6D-7945E7D4F188 @default.
- Q90466619 P2093 Q90466619-3F236953-4272-4656-9D46-6EB9763CB5BB @default.
- Q90466619 P2093 Q90466619-48D78113-99CA-4E30-A786-55A7AC132DD3 @default.
- Q90466619 P2093 Q90466619-732C2A68-D7CC-4AA3-B3BD-D46B3F3534AD @default.
- Q90466619 P2093 Q90466619-7830BAAA-939F-45F8-B013-21746C466BA2 @default.
- Q90466619 P2093 Q90466619-7986E480-45E7-4042-B49D-D5FFA175C31C @default.
- Q90466619 P2093 Q90466619-8F1E5056-DA2A-4223-A172-100F50A57212 @default.
- Q90466619 P2093 Q90466619-8F2B14DA-0B28-4695-B906-A4F1E3E938DC @default.
- Q90466619 P2093 Q90466619-AED21761-B36B-4AE8-82FD-7E2902AB58D9 @default.
- Q90466619 P2093 Q90466619-C14CA525-579A-413C-87A0-22100D1648B1 @default.
- Q90466619 P2093 Q90466619-C5BE5353-4EF5-4656-AF4D-824E8FF3BFA6 @default.
- Q90466619 P2093 Q90466619-CCB77686-1533-4F85-BE5D-72F05A833613 @default.
- Q90466619 P2093 Q90466619-CDE070E8-D5A3-4B35-A3F7-E5CC0B47211B @default.
- Q90466619 P2093 Q90466619-DED7FDD9-B9FC-481B-9289-834FE43003B8 @default.
- Q90466619 P2093 Q90466619-EC9A269F-6F6D-4E02-A4D7-B7A3CF1DE945 @default.
- Q90466619 P2093 Q90466619-F8450808-844F-4577-8CA6-E7C4AE457B96 @default.
- Q90466619 P2093 Q90466619-FA26B8B3-08BD-46A2-93A8-71695D55C1DB @default.
- Q90466619 P304 Q90466619-87B8246E-CD4B-428E-A763-D8AA7DA82688 @default.
- Q90466619 P31 Q90466619-B2B04ABD-8186-4239-B151-20D691C58B3C @default.
- Q90466619 P356 Q90466619-18D9718B-7DAF-43E7-922C-58B20F6AB110 @default.
- Q90466619 P433 Q90466619-25BFE07D-0223-4B1F-87D5-ACFBA431E1F6 @default.
- Q90466619 P478 Q90466619-9C2CA2D9-3887-4F97-9781-5319AC564FFB @default.
- Q90466619 P50 Q90466619-4988D1E4-7574-4C28-8226-96EDC7C8410A @default.
- Q90466619 P50 Q90466619-4C8A2185-B148-403C-AECD-753D0C624BA3 @default.
- Q90466619 P50 Q90466619-5BC6BB0E-1903-416C-BD1E-D981B7AD611F @default.
- Q90466619 P50 Q90466619-F368C295-95D4-4200-8CB3-80A40594DAE0 @default.
- Q90466619 P577 Q90466619-917AF26D-E56F-44B6-9A42-130E0533E705 @default.
- Q90466619 P698 Q90466619-AC62237B-A91A-4AA4-A150-EEDCB9B7E867 @default.
- Q90466619 P356 1535-7163.MCT-19-0019 @default.
- Q90466619 P698 31582533 @default.
- Q90466619 P1433 Q2363144 @default.
- Q90466619 P1476 "The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models" @default.
- Q90466619 P2093 "Andreas Schlicker" @default.
- Q90466619 P2093 "Antje M Wengner" @default.
- Q90466619 P2093 "Bernard Haendler" @default.
- Q90466619 P2093 "Christoph A Schatz" @default.
- Q90466619 P2093 "Dieter Moosmayer" @default.
- Q90466619 P2093 "Dominik Mumberg" @default.
- Q90466619 P2093 "Franz von Nussbaum" @default.
- Q90466619 P2093 "Gerhard Siemeister" @default.
- Q90466619 P2093 "Karl Ziegelbauer" @default.
- Q90466619 P2093 "Michael Brands" @default.
- Q90466619 P2093 "Pascale Lejeune" @default.
- Q90466619 P2093 "Philip Lienau" @default.
- Q90466619 P2093 "Simon J Baumgart" @default.
- Q90466619 P2093 "Sven Golfier" @default.
- Q90466619 P2093 "Ulf Bömer" @default.
- Q90466619 P2093 "Uwe Eberspächer" @default.
- Q90466619 P304 "26-38" @default.
- Q90466619 P31 Q13442814 @default.
- Q90466619 P356 "10.1158/1535-7163.MCT-19-0019" @default.
- Q90466619 P433 "1" @default.
- Q90466619 P478 "19" @default.
- Q90466619 P50 Q60332427 @default.
- Q90466619 P50 Q60619092 @default.
- Q90466619 P50 Q80066452 @default.
- Q90466619 P50 Q88567514 @default.
- Q90466619 P577 "2019-10-03T00:00:00Z" @default.
- Q90466619 P698 "31582533" @default.